ZT:我们医院免费胃癌的CLINICAL TRIAL工作关系,发贴不便,请转田牛妈
by 看手相518
Title AMN107 Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib - GIST
Phase III
Modality Signal Transduction Inhibitor
Sponsor Type Private
Title PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer Patients - GIST
Phase III
Modality Complementary and Alternative Therapy
Sponsor Type Private
Title Sunitinib (SU11248, Sutent) Versus Imatinib Mesylate (Gleevec) for Gastrointestinal Stromal Tumors (GIST)
Phase III
Modality Signal Transduction Inhibitor
Sponsor Type Private
Title Nilotinib Patients With GIST Resistant or Intolerant to Imatinib and or to 2nd Line Tyrosine Kinas (TK) Inhibitor
Phase II
Modality Signal Transduction Inhibitor
Sponsor Type Private
Title XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib - Gastrointestinal Stromal Tumor (GIST)
Phase II
Modality Signal Transduction Inhibitor
Sponsor Type Private
Title Neuropathic Pain in Patients With Cancer - GIST
Phase I / II
Modality Complementary and Alternative Therapy, Signal Transduction Inhibitor
Sponsor Type Private
Title Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients - Gastrointestinal Stromal Tumor (GIST)
Phase I / II
Modality Signal Transduction Inhibitor
Sponsor Type Private
Title Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Gamma Interferon in Previously Vaccinated Patients - GIST
Phase I
Modality Biological Therapy
Sponsor Type Private
Title Oral EGFR Inhibitor, AV-412, Administered Three Times Weekly in Advanced Solid Tumor Patients - GIST
Phase I
Modality Signal Transduction Inhibitor
Sponsor Type Private
Title PF-00299804 in Treating Patients With Advanced Malignant Solid Tumors - Gastrointestinal Stromal Tumor (GIST)
Phase I
Modality Signal Transduction Inhibitor
Sponsor Type Private